Though an antiretroviral medication called PrEP provides near-perfect protection against HIV, patients must often surmount ...

The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...

Long-term Medicaid expansion was linked to substantial growth in PrEP prescribing, with earlier expansion states seeing far ...

HOUSTON — The fight against HIV has come a long way, and new advancements in prevention are changing the game. One of the latest breakthroughs is a long-lasting injectable form of PrEP (pre-exposure ...

HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...

ATLANTA — Five years ago, the U.S. government unveiled a plan to end the HIV epidemic by 2030. More than 30,000 people are diagnosed with HIV every year in this country. But this is not a problem for ...

Friday marks the 35th anniversary of World AIDS Day, an international moment to remember, reflect and educate people on the HIV/AIDS epidemic that started over four decades ago. But due to ...

Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention ...

Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...

At least 1.4 million Kenyans are living with HIV, with approximately 21,009 people estimated to have died from AIDS-related ...

Speaking at the J.P. Morgan Healthcare Conference 2026, CEO Daniel O’Day said that the company has seven pipeline drugs for ...

"Pre-exposure prophylaxis (PrEP) is the most important concept in the [HIV] prevention field today," Robert Grant told the Infectious Disease Society of America at their annual meeting in San Diego.